Search

Elaine M Weidenhammer

age ~59

from San Diego, CA

Also known as:
  • Eileen M Weidenhammer
  • Elaine M Weidenhamme
Phone and address:
3412 Utah St, San Diego, CA 92104
(619)2912682

Elaine Weidenhammer Phones & Addresses

  • 3412 Utah St, San Diego, CA 92104 • (619)2912682
  • 3740 Promontory St, San Diego, CA 92109 • (858)2727232
  • Pittsburgh, PA
  • Gaithersburg, MD
  • Lancaster, PA

Work

  • Company:
    Legacy health strategies
    Jul 2014
  • Position:
    Vp, program design and analytics

Education

  • Degree:
    Master of Business Administration, Masters
  • School / High School:
    University of California, San Diego - Rady School of Management
    2004 to 2006

Skills

Biotechnology • Medical Devices • Molecular Biology • Commercialization • Competitive Analysis • Personalized Medicine • Product Launch • Program Management • Cell • Lifesciences • Clinical Development • Cross Functional Team Leadership • Product Development • Marketing Strategy • Market Development • Oncology • Infectious Diseases • Healthcare • Diagnostics • Patient Education and Support Programs

Languages

English

Industries

Biotechnology

Us Patents

  • Quantitative Analysis Methods On Active Electronic Microarrays

    view source
  • US Patent:
    6492122, Dec 10, 2002
  • Filed:
    Oct 10, 2001
  • Appl. No.:
    09/975408
  • Inventors:
    Elaine M. Weidenhammer - San Diego CA
    Ling Wang - San Diego CA
    Xiao Xu - San Diego CA
    Michael J. Heller - Encinitas CA
    Brenda F. Kahl - San Diego CA
  • Assignee:
    Nanogen, Inc. - San Diego CA
  • International Classification:
    C12Q 168
  • US Classification:
    435 6, 435 71, 435 911, 435 912, 4352872, 536 221, 536 231, 536 243, 536 2431, 536 2432, 536 2433
  • Abstract:
    The present invention presents techniques useful in methods for gene expression monitoring, and other nucleic acid hybridization assays, that utilize microelectronic arrays to drive the transport and hybridization of nucleic acids. Particularly, methods for normalizing the signals of individual microlocations by the use of an internal control sequence probe are provided. These methods are particularly useful for hybridization assays in which a quantitative comparison of the hybridization of several different sequences at a plurality of microlocations is desired, such as in gene expression analyses.
  • Primer Extension Detection Methods On Active Electronic Microarrays

    view source
  • US Patent:
    20020119484, Aug 29, 2002
  • Filed:
    Feb 12, 2002
  • Appl. No.:
    10/075579
  • Inventors:
    Elaine Weidenhammer - San Diego CA, US
    Xiao Xu - San Diego CA, US
    Michael Heller - Encinitas CA, US
    Brenda Kahl - San Diego CA, US
  • Assignee:
    Nanogen, Inc. - San Diego CA
  • International Classification:
    C12Q001/68
    G06F019/00
    C12P019/34
    G01N033/48
    G01N033/50
  • US Classification:
    435/006000, 702/020000, 435/091200
  • Abstract:
    The present invention presents methods for gene expression monitoring that utilize microelectronic arrays to drive the transport and hybridization of nucleic acids. Procedures are described for generating mRNA expression samples for use in these methods from populations of cells, tissues, or other biological source materials, that may differ in their physiological and/or pathological state. Provided in the invention are methods for generating a reusable nucleic acid transcript library from mRNA in a sample of biological material. In order to improve gene expression monitoring on the microelectronic arrays, the transcripts are amplified to produce sample nucleic acid amplicons of a defined length. Because multiple sample amplicons may be selectively hybridized to controlled sites in the electronic array, the gene expression profiles of the polynucleotide populations from different sources can be directly compared in an array format using electronic hybridization methodologies. Also provided in the invention are methods for detecting the level of sample amplicons using electronically assisted primer extension detection, and utilizing individual test site hybridization controls. The hybridization data collected utilizing the improved methods of the present invention will allow the correlation of changes in mRNA level with the corresponding expression of the encoded protein in the biological source material, and thus aid in studying the role of gene expression in disease.
  • Methods For Gene Expression Monitoring On Electronic Microarrays

    view source
  • US Patent:
    6379897, Apr 30, 2002
  • Filed:
    Nov 9, 2000
  • Appl. No.:
    09/710200
  • Inventors:
    Elaine M. Weidenhammer - San diego CA
    Ling Wang - San diego CA
    Xiao Xu - San diego CA
    Michael J. Heller - Encinitas CA
    Brenda F. Kahl - San Diego CA
  • Assignee:
    Nanogen, Inc. - San Diego CA
  • International Classification:
    C12Q 168
  • US Classification:
    435 6, 435 71, 435 911, 435 912, 4352852, 4352872, 536 221, 536 231, 536 243, 536 2431, 536 2432, 536 2433
  • Abstract:
    The present invention presents methods for gene expression monitoring that utilize microelectronic arrays to drive the transport and hybridization of nucleic acids. Procedures are described for generating mRNA expression samples for use in these methods from populations of cells, tissues, or other biological source materials, that may differ in their physiological and/or pathological state. Provided in the invention are methods for generating a reusable nucleic acid transcript library from mRNA in a sample of biological material. In order to improve gene expression monitoring on the microelectronic arrays, the transcripts are amplified to produce sample nucleic acid amplicons of a defined length. Because multiple sample amplicons may be selectively hybridized to controlled sites in the electronic array, the gene expression profiles of the polynucleotide populations from different sources can be directly compared in an array format using electronic hybridization methodologies. Also provided in the invention are methods for detecting the level of sample amplicons using electronically assisted primer extension detection, and utilizing individual test site hybridization controls.

Resumes

Elaine Weidenhammer Photo 1

Vp, Program Design And Analytics

view source
Location:
3412 Utah St, San Diego, CA 92104
Industry:
Biotechnology
Work:
Legacy Health Strategies
Vp, Program Design and Analytics

Consultant Jan 2012 - Jul 2014
Marketing and Online Content Consulting

Resmed Jan 2008 - Jan 2012
Director, Patient and Physician Initiatives

Nanogen Feb 1998 - Nov 2007
Associate Director, Strategic Market Development
Education:
University of California, San Diego - Rady School of Management 2004 - 2006
Master of Business Administration, Masters
Carnegie Mellon University 1989 - 1995
Doctorates, Doctor of Philosophy, Molecular Biology
Skills:
Biotechnology
Medical Devices
Molecular Biology
Commercialization
Competitive Analysis
Personalized Medicine
Product Launch
Program Management
Cell
Lifesciences
Clinical Development
Cross Functional Team Leadership
Product Development
Marketing Strategy
Market Development
Oncology
Infectious Diseases
Healthcare
Diagnostics
Patient Education and Support Programs
Languages:
English

Youtube

Elaine Weiner-Reed 2020 Studio Tour

Elaine came into her art the way many of MFA's artists do - by acciden...

  • Duration:
    8m 20s

Elaine

Provided to YouTube by Dependent Elaine Beborn Beton Truth 1997 Depe...

  • Duration:
    3m 45s

2022 Elaine King Player Of The Year Award

Finalists: Paige Pierce, Catrina Allen, Kristin Tattar Don't miss the ...

  • Duration:
    2m 2s

Facebook

Elaine Weidenhammer Photo 2

Elaine Britt Weidenhammer

view source
Elaine Weidenhammer Photo 3

Elaine Weidenhammer

view source
Friends:
Deborah Payne, Wolfgang Trautwein, Susan Shelby, Niall O'Donnell, Janet White

Get Report for Elaine M Weidenhammer from San Diego, CA, age ~59
Control profile